Monographie - Thiopental sodium

Pēdējā atjaunošana :
14/12/2024

Thiopental sodium

Ķīmiskā uzbūve

Oriģinālais nosaukums

Tirdzniecības nosaukumi ir apzīmējoši un palīgvielas var atšķirties dažādām valstīm un laboratorijām

Anapental	Ēģipte
Anental	Kolumbija, Venecuēla
Epental	Saūda Arābija
Exipental	Irāna
Farmotal	Itālija
Gabapentax	Kolumbija
Hipnopento	Argentīna
Nesdonal	Holande
Pantul	Ekvadora, Peru
Pensodital	Meksika
Pental	Turcija
Pentarim	Meksika
Pentax	Venecuēla
Pentocur	Islande, Norvēģija
Pentotex	Malaizija
Pentothal	Austrālija, Beļģija, Dānija, Grieķija, Itālija, Kanāda, Luksemburga, Meksika, Somija, Šveice, Zviedrija
Sodipental	Kolumbija, Meksika
Thiojex	Čīle
Thiomek	Peru
Thiopental	Austrija, Ēģipte, Francija, Grieķija, Irāna, Īrija, Lielbritānija, Malaizija, Maroka, Polija, Rumānija, Saūda Arābija, Tunisija, Ungārija, Vācija
Thiopentax	Ekvadora, Venecuēla
Tiobarbital	Kolumbija, Spānija
Trapanal	Vācija
Zedisol	Meksika

Literatūras saraksts : Thiopental sodium

	tips	publicēšana
59	Žurnāls	Trissel LA, Gilbert DL, Martinez JF, Kim MC. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
125	Žurnāls	Chernin EL, Stewart JT, Smiler B. Stability of thiopental sodium and propofol in polypropylene syringes at 23 and 4°C. Am J Health-Syst Pharm 1996 ; 53: 1576-1579.
126	Žurnāls	Prankerd RJ, Jones RD. Physicochemical compatibility of propofol with thiopental sodium. Am J Health-Syst Pharm 1996 ; 53: 2606-2610.
299	Žurnāls	Trissel LA, Martinez JF, Gilbert DL. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
314	Žurnāls	Chiu MF, Schwartz ML. Visual compatibility of injectable drugs used in the intensive care unit. Am J Health-Syst Pharm 1997 ; 54: 64-65.
319	Žurnāls	Hadzija BW, Lubarsky DA. Compatibility of etomidate, thiopental sodium, and propofol injections with drugs commonly administered during induction of anesthesia. Am J Health-Syst Pharm 1995 ; 52: 997-999.
350	Žurnāls	Martens HJ, De Goede PN, Van Loenen AC. Sorption of various drugs in polyvinyl chloride, glass, and polyethylene-lined infusion containers. Am J Hosp Pharm 1990 ; 47: 369-373.
527	Žurnāls	Das Gupta V, Neal Gardner S, Jolowsky CM, Newcomer DR, Stewart KR. Chemical stability of thiopental sodium injection in disposable plastic syringes. J Clin Pharm Ther 1987 ; 12: 339-342.
642	Žurnāls	Baumgartner TG, Knudsen AK, Dunn AJ, Kilroy RA. Norepinephrine stability in saline solutions. Hosp Pharm 1988 ; 23: 44,49, 59.
755	Laboratorija	Pancuronium (Pavulon®) - Résumé des caractéristiques du produit MSD France 2016
871	Žurnāls	Haws JL, Herman N, Clark Y, Bjoraker R, Jones D. The chemical stability and sterility of sodium thiopental after preparation. Anesth Analg 1998 ; 86: 208-213.
919	Žurnāls	Lazar ER, Jolly DT, Tam YK, Hrazdil J, Tawfik SR, Clanachan AS. Propofol and thiopental in a 1:1 volume mixture is chemically stable. Anesth Analg 1998 ; 86: 422-426.
1173	Žurnāls	Kowaluk EA, Roberts MS, Blackburn HD, Polack AE. Interactions between drugs and polyvinyl chloride infusion bags. Am J Hosp Pharm 1981 ; 38: 1308-1314.
1713	Žurnāls	Trissel LA, Saenz CA. Compatibility screening of bivalirudin during simulated Y-site administration with other drugs. Int J Pharm Compound 2002 ; 6: 311-315.
1721	Žurnāls	Trissel LA, Williams KY, Baker MB. Compatibility screening of Hextend during simulated Y-site administration with other drugs. Int J Pharm Compound 2001 ; 5: 69-72.
1803	Žurnāls	Trissel, LA, Saenz CA, Ogundele OB, Ingram D, Baker MB. Compatibility of fenoldopam mesylate with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2003 ; 60: 80-85.
2073	Žurnāls	Taniguchi T, Yamamoto K, Kobayashi T. Precipitate formed by thiopentone and vecuronium causes pulmonary embolism. Can J Anesth 1998 ; 45: 347-351.
2079	Žurnāls	Morton WD, Lerman J. The effect of pancuronium on the solubility of aqueous thiopentone. Can J Anesth 1987 ; 34: 87-89.
2090	Žurnāls	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
2105	Žurnāls	Valverde molina F, Hernandez Hernandez G, Munoz Castillo M, Novales Duran J, Gallego Fernandez C. Estabilidad de una mezcla de etomidato y pentotal para administracion intravenosa en bolo. Farm Hosp 1999 ; 23: 357-360.
2146	Žurnāls	Trissel LA, Xu QA, Baker M. Drug compatibility with new polyolefin infusion solution containers. Am J Health-Syst Pharm 2006 ; 63: 2379-2382.
2231	Žurnāls	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3134	Žurnāls	Perez Jua En, Maqueda Palau M, Arévalo Rubert Mt, Ribas Nicolau B, Amoros Cerdà SM. Compatibilidad visual y física de la furosemida en mezclas intravenosas para perfusión continua. Enferm Intensiva 2010 ; 21: 96-103.
3212	Žurnāls	Ribas Nicolau, B.; P?rez Juan, E.; Amor?s Cerd?, S.M.; Ar?valo Rubert, M.J.; Maqueda Palau, M. Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos. Enferm Intensiva 2011 ;22:78-82.
3372	Žurnāls	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3373	Žurnāls	Khan S, Stannard N, Greijn J. Precipitation of thiopental with muscle relaxants: a potential hazard. J R Soc Med Sh Rep 2011 ; 2: 58.
3377	Žurnāls	Huddy NC, Durcan JJ. Precipitation betwen meptazinol and thiopentone. Anaesthesia 1983 ; 38: 601-602.
3408	Žurnāls	Tollec S, Touzin K, Pelletier E, Forest J.M. Evaluation visuelle de la compatibilité physique de la naloxone avec d’autres médicaments intraveineux usuels. Pharmactuel 2013 ; 46, 1 : 16-21.
3464	Žurnāls	Monica Maqueda-Palau, Eva Pérez-Juan, Maria Josep Arévalo-Rubert, Sylvia Monica Amoros-Cerda, Bàrbara Ribas-Nicolau. Compatibilidad física de la amiodarona en perfusión continua Enferm Clin 2011 21:25-29.
3466	Žurnāls	B. Ribas Nicolau, E. P?rez Juan, S.M. Amor?s Cerd?, M.J. Ar?valo Rubert, M. Maqueda Palau. Compatibilidad física del bicarbonato sódico con fármacos de uso frecuente en la unidad de cuidados intensivos Enferm Intensiva 2011 ;22:78-82.
3501	Laboratorija	Ketamine hydrochloride (Ketalar®) - Summary of Product Characteristics Pfizer 2011
3503	Laboratorija	Fentanyl - Summary of product Characteristics Hameln Pharmaceuticals 2012
3525	Laboratorija	Pethidine hydrochloride - Summary of product Characteristics AMCO Amdipharm Mercury 2012
3526	Laboratorija	Clindamycin (Dalacin®) - Summary of Product Characteristics Pharmacia 2010
3531	Laboratorija	Morphine sulphate 10 mg/mL injection BP – Summary of Product Characteristics Wockhardt 2014
3549	Laboratorija	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3564	Laboratorija	Rocuronium B Braun - Résumé des caractéristiques du produit. B Braun 2012
3599	Laboratorija	Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics Amco Amdipharm Mercry 2013
3600	Laboratorija	Hydroxyzine (Atarax®) - Résumé des caractéristiques du produit UCB Pharma SA 2009
3601	Laboratorija	Cisatracurium Actavis - Résumé des Caractéristiques du Produit Actavis 2012
3607	Laboratorija	Esmolol hydrochloride for injection - Summary of Product Characteristics AOP Orphan Pharmaceuticals AG 2013
3612	Laboratorija	Doxapram (Dopram) - Summary of Product Characteristics Amdipharm Mercury Company 2012
3614	Laboratorija	Nicardipine Injection - Summary of Product Characteristics American Regent Inc 2013
3629	Laboratorija	Atracurium (Atracurium solution for injection/infusion®) - Summary of Product Characteristics Actavis UK 2014
3630	Laboratorija	Vecuronium (Norcuron®) - Summary of Product Characteristics Merck Sharp Dohme 2012
3631	Laboratorija	Suxamethonium (Suxamethonium Aguettant®) - Résumé des caractéristiques du produit Aguettant 2016
3674	Laboratorija	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3675	Laboratorija	Thiopental sodium - Summary of Product Characteristics Archimedes Pharma UK Ltd 2015
3676	Laboratorija	Atracurium bésilate (Atracurium Hospira®) - Résumé des caractéristiques du produit Hospira 2014
3767	Žurnāls	Legris M.E, Lavoie A, Forrest J.M, Hildgen P. Compatibilité par évaluation visuelle du thiopental injectable lors de son administration en Y avec des médicaments usuels. Pharmactuel 2014 ; 47, 3 : 167-172.
3823	Žurnāls	Juan E.P, Palau M.M, Cerd? S.A, Rubert M.A, Nicolau B.R. Compatibilité physique de médicaments administrés dans l’unité de soins intensifs Pharmactuel 2015 ; 48, 3 : 146-152.
3932	Laboratorija	Hydroxocobalamine (Cyanokit®) - Résumé des caractéristiques du produit Serb Laboratoire 2015
3941	Laboratorija	Nicardipine - Summary of Product Characteristics Concordia International 2017
4009	Laboratorija	Droperidol - Résumé des Caractéristiques du Produit Panpharma 2017
4428	Žurnāls	Rashed S.M, Sweatman T.W, Thoma L, Hovinga C.A, Phelps S.J. Chemical Compatibility of Depacon® with Medications Frequently Administered by Intravenous Y-Site Delivery in Patients with Epilepsy or Head Trauma. J Pediatr Pharmacol Ther 2004 ; 9, 2: 126-132.
4700	Laboratorija	Esketamine 25 mg/mL solution for injection/infusion. - Summary of Product Characteristics AS Kalceks 2022

Mentions Légales